BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33461416)

  • 1. Myositis in systemic lupus erythematosus.
    Cotton T; Niaki OZ; Zheng B; Pineau CA; Fritzler M; Vinet E; Clarke AE; Bernatsky S
    Lupus; 2021 Apr; 30(4):615-619. PubMed ID: 33461416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis.
    Cotton T; Fritzler MJ; Choi MY; Zheng B; Niaki OZ; Pineau CA; Lukusa L; Bernatsky S
    Lupus; 2022 Oct; 31(12):1477-1484. PubMed ID: 36018314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLE myopathy: a clinicopathological study.
    Jakati S; Rajasekhar L; Uppin M; Challa S
    Int J Rheum Dis; 2015 Nov; 18(8):886-91. PubMed ID: 25963652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
    Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
    Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort.
    Zhao L; Huang W; Wang H; Chen J; Zhang D; Wang X; Sun F; Ye S
    Int J Rheum Dis; 2023 Jan; 26(1):51-59. PubMed ID: 36117395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous vasculitis in SLE.
    Kallas R; Goldman D; Petri MA
    Lupus Sci Med; 2020 Sep; 7(1):. PubMed ID: 32963114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters.
    Lim KL; Abdul-Wahab R; Lowe J; Powell RJ
    Ann Rheum Dis; 1994 Mar; 53(3):178-82. PubMed ID: 8154935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus.
    Barbacki A; Rached-d'Astous N; Pineau CA; Vinet E; Grenier LP; Kalache F; Fallavollita S; Lukusa L; Bernatsky S
    J Clin Rheumatol; 2022 Mar; 28(2):e488-e490. PubMed ID: 35192594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into systemic lupus erythematosus: a retrospective observational study of clinical features, autoantibodies, and gender-related differences.
    Adwan MH; Qasem U; Atawnah SY; Itmeizeh M; Hanbali R; Alsoofi NA; Jbara MA; AbuHelal A; Alnaimat F
    Rheumatol Int; 2024 Jul; 44(7):1255-1263. PubMed ID: 38717538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter lupus register from Argentina, the RELESSAR database: Influence of ethnicity on disease phenotype.
    García MA; Alba P; Del Campo-Perez V; Roverano S; Quintana RM; Alvarez AP; Graf CE; Pisoni C; Spindler A; Gomez C; Figueredo HM; Papasidero S; Paniego R; de la Vega MC; Civit E; Gonzalez Lucero L; Martire MV; Aguila Maldonado R; Gordon S; Gobbi C; Micelli M; Nieto R; Rausch G; Gongora V; Damico A; Dubinsky D; Orden A; Zacariaz J; Romero J; Pera M; Goñi M; Rillo O; Baez R; Arturi V; Gonzalez A; Vivero F; Bedoya ME; Shmid MM; Caputo V; Larroude MS; Dominguez N; Gómez GN; Rodriguez GN; Marin J; Collado V; Jorfen M; Bedran Z; Curti A; Gazzoni MV; Sarano J; Zelaya M; Sacnun M; Finucci Curi P; Rojas Tessel R; Arias Saavedra M; Sattler ME; Machado Escobar MA; Astesana P; Paris U; Virasoro BM; Santa Cruz MJ; Allievi A; Vandale JM; Hojberg NG; Pons-Estel B
    Lupus; 2022 Apr; 31(5):637-645. PubMed ID: 35382633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histopathological features of myositis in systemic lupus erythematosus.
    Tiniakou E; Goldman D; Corse A; Mammen A; Petri MA
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35351810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
    Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
    Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory myositis in systemic lupus erythematosus.
    Bitencourt N; Solow EB; Wright T; Bermas BL
    Lupus; 2020 Jun; 29(7):776-781. PubMed ID: 32281474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache, Raynaud's syndrome and serotonin receptor agonists in systemic lupus erythematosus.
    Bernatsky S; Pineau CA; Lee JL; Clarke AE
    Lupus; 2006; 15(10):671-4. PubMed ID: 17120594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound characterization of the nail bed in patients with systemic lupus erythematosus.
    Ferrusquia-Toriz D; Hernández-Díaz C; Amezcua-Guerra LM; Ventura-Ríos L; Higuera-Ortiz V; Lozada-Navarro AC; Silveira LH
    Lupus; 2021 Apr; 30(4):608-614. PubMed ID: 33470159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.
    Calvo-Alen J; Alarcon GS; Burgard SL; Burst N; Bartolucci AA; Williams HJ
    J Rheumatol; 1996 Mar; 23(3):469-75. PubMed ID: 8832985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.
    Dimant J; Ginzler E; Schlesinger M; Sterba G; Diamond H; Kaplan D; Weiner M
    Arthritis Rheum; 1979 Aug; 22(8):815-9. PubMed ID: 465096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.